Your browser doesn't support javascript.
loading
Next-Generation JAK2 Inhibitors for the Treatment of Myeloproliferative Neoplasms: Lessons from Structure-Based Drug Discovery Approaches.
Nair, Pramod C; Piehler, Jacob; Tvorogov, Denis; Ross, David M; Lopez, Angel F; Gotlib, Jason; Thomas, Daniel.
Afiliação
  • Nair PC; Cancer Program, South Australian Health and Medical Research Institute (SAHMRI), University of Adelaide, Adelaide, Australia.
  • Piehler J; Discipline of Medicine, Adelaide Medical School, The University of Adelaide, Adelaide, Australia.
  • Tvorogov D; Discipline of Clinical Pharmacology, Flinders Health and Medical Research Institute (FHMRI) Cancer Program, College of Medicine and Public Health, Flinders University, Adelaide, Australia.
  • Ross DM; Department of Biology and Center of Cellular Nanoanalytics, University of Osnabrück, Osnabrück, Germany.
  • Lopez AF; Centre for Cancer Biology, University of South Australia and SA Pathology, Adelaide, Australia.
  • Gotlib J; Cancer Program, South Australian Health and Medical Research Institute (SAHMRI), University of Adelaide, Adelaide, Australia.
  • Thomas D; Discipline of Medicine, Adelaide Medical School, The University of Adelaide, Adelaide, Australia.
Blood Cancer Discov ; 4(5): 352-364, 2023 09 01.
Article em En | MEDLINE | ID: mdl-37498362

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Inibidores de Janus Quinases / Transtornos Mieloproliferativos / Neoplasias Limite: Humans Idioma: En Revista: Blood Cancer Discov Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Austrália País de publicação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Inibidores de Janus Quinases / Transtornos Mieloproliferativos / Neoplasias Limite: Humans Idioma: En Revista: Blood Cancer Discov Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Austrália País de publicação: Estados Unidos